Remegen Co. Ltd

Remegen Co. Ltd

World Rank (Jan-05-2024)
3,721
Market Cap (Jan-05-2024)
3.708 Billion USD
World Rank (Jul-30-2023)
3,105
Market Cap (Jul-30-2023)
4.744 Billion USD
World Rank (Jan-07-2022)
3,945
Market Cap (Jan-07-2022)
3.944 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 479
Headquarters Country
China
Employee Count
134
Employee Count as of Date
As on Jan-2022
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
207 Million USD
Annual Net Income in USD
40 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
605 Million USD
Total Liabilities in USD
104 Million USD
Total Equity in USD
501 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
REMEGEN CO., LTD.
Company Profile
RemeGen Co., Ltd is a traditional Chinese medicine company committed to the discovery development and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune oncology and ophthalmic diseases. The headquarters is in China.
Stock Exchange
HKeX

Share